# A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease

> **NCT00969332** · PHASE2 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 62 (actual)

## Conditions studied

- Cholestasis

## Interventions

- **DRUG:** Omegaven

## Key facts

- **NCT ID:** NCT00969332
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2019-01-12
- **Final completion:** 2019-02-12
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** study intervention was approved by the FDA
- **Last updated:** 2020-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969332, "A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00969332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*